Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice

Zhou L, Pelengaris S, Abouna S, Young J, Epstein D, Herold J, Nattkemper TW, Nakhai H, Khan M (2012)
PLoS ONE 7(9): e43623.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Zhou, Luxian; Pelengaris, Stella; Abouna, Sylvie; Young, James; Epstein, David; Herold, JuliaUniBi; Nattkemper, Tim WilhelmUniBi ; Nakhai, Hassan; Khan, Michael
Einrichtung
Centrum für Biotechnologie
Abstract / Bemerkung
Background: The key factors which support re-expansion of beta cell numbers after injury are largely unknown. Insulin-like growth factor II (IGF-II) plays a critical role in supporting cell division and differentiation during ontogeny but its role in the adult is not known. In this study we investigated the effect of IGF-II on beta cell regeneration. Methodology/Principal Findings: We employed an in vivo model of 'switchable' c-Myc-induced beta cell ablation, pIns-cMycER(TAM), in which 90% of beta cells are lost following 11 days of c-Myc (Myc) activation in vivo. Importantly, such ablation is normally followed by beta cell regeneration once Myc is deactivated, enabling functional studies of beta cell regeneration in vivo. IGF-II was shown to be re-expressed in the adult pancreas of pIns-c-MycER(TAM)/IGF-II+/+ (MIG) mice, following beta cell injury. As expected in the presence of IGF-II beta cell mass and numbers recover rapidly after ablation. In contrast, in pIns-c-MycER(TAM)/IGF-II+/- (MIGKO) mice, which express no IGF-II, recovery of beta cell mass and numbers were delayed and impaired. Despite failure of beta cell number increase, MIGKO mice recovered from hyperglycaemia, although this was delayed. Conclusions/Significance: Our results demonstrate that beta cell regeneration in adult mice depends on re-expression of IGF-II, and supports the utility of using such ablation-recovery models for identifying other potential factors critical for underpinning successful beta cell regeneration in vivo. The potential therapeutic benefits of manipulating the IGF-II signaling systems merit further exploration.
Erscheinungsjahr
2012
Zeitschriftentitel
PLoS ONE
Band
7
Ausgabe
9
Art.-Nr.
e43623
ISSN
1932-6203
eISSN
1932-6203
Page URI
https://pub.uni-bielefeld.de/record/2536156

Zitieren

Zhou L, Pelengaris S, Abouna S, et al. Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice. PLoS ONE. 2012;7(9): e43623.
Zhou, L., Pelengaris, S., Abouna, S., Young, J., Epstein, D., Herold, J., Nattkemper, T. W., et al. (2012). Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice. PLoS ONE, 7(9), e43623. doi:10.1371/journal.pone.0043623
Zhou, Luxian, Pelengaris, Stella, Abouna, Sylvie, Young, James, Epstein, David, Herold, Julia, Nattkemper, Tim Wilhelm, Nakhai, Hassan, and Khan, Michael. 2012. “Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice”. PLoS ONE 7 (9): e43623.
Zhou, L., Pelengaris, S., Abouna, S., Young, J., Epstein, D., Herold, J., Nattkemper, T. W., Nakhai, H., and Khan, M. (2012). Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice. PLoS ONE 7:e43623.
Zhou, L., et al., 2012. Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice. PLoS ONE, 7(9): e43623.
L. Zhou, et al., “Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice”, PLoS ONE, vol. 7, 2012, : e43623.
Zhou, L., Pelengaris, S., Abouna, S., Young, J., Epstein, D., Herold, J., Nattkemper, T.W., Nakhai, H., Khan, M.: Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice. PLoS ONE. 7, : e43623 (2012).
Zhou, Luxian, Pelengaris, Stella, Abouna, Sylvie, Young, James, Epstein, David, Herold, Julia, Nattkemper, Tim Wilhelm, Nakhai, Hassan, and Khan, Michael. “Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice”. PLoS ONE 7.9 (2012): e43623.

3 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Early life antibiotic exposure affects pancreatic islet development and metabolic regulation.
Li J, Yang K, Ju T, Ho T, McKay CA, Gao Y, Forget SK, Gartner SR, Field CJ, Chan CB, Willing BP., Sci Rep 7(), 2017
PMID: 28150721
Menin and PRMT5 suppress GLP1 receptor transcript and PKA-mediated phosphorylation of FOXO1 and CREB.
Muhammad AB, Xing B, Liu C, Naji A, Ma X, Simmons RA, Hua X., Am J Physiol Endocrinol Metab 313(2), 2017
PMID: 28270438
A CCR2+ myeloid cell niche required for pancreatic β cell growth.
Mussar K, Pardike S, Hohl TM, Hardiman G, Cirulli V, Crisa L., JCI Insight 2(15), 2017
PMID: 28768911

43 References

Daten bereitgestellt von Europe PubMed Central.

Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrin M, Gros L, Bosch F., J. Clin. Invest. 105(6), 2000
PMID: 10727441
Clinical studies of liraglutide, a novel, once-daily human glucagon-like peptide-1 analog for improved management of type 2 diabetes mellitus.
Drab SR., Pharmacotherapy 29(12 Pt 2), 2009
PMID: 19947816
beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass.
Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR., Nat. Genet. 31(1), 2002
PMID: 11923875
Beta cell expression of IGF-I leads to recovery from type 1 diabetes.
George M, Ayuso E, Casellas A, Costa C, Devedjian JC, Bosch F., J. Clin. Invest. 109(9), 2002
PMID: 11994404
Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.
Pelengaris S, Khan M, Evan GI., Cell 109(3), 2002
PMID: 12015982
Placental-specific IGF-II is a major modulator of placental and fetal growth.
Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W., Nature 417(6892), 2002
PMID: 12087403
The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice.
Rolin B, Larsen MO, Gotfredsen CF, Deacon CF, Carr RD, Wilken M, Knudsen LB., Am. J. Physiol. Endocrinol. Metab. 283(4), 2002
PMID: 12217892
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ., J. Biol. Chem. 278(1), 2002
PMID: 12409292
Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy.
De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA., Diabetes 52(2), 2003
PMID: 12540609
Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan.
Rooman I, Bouwens L., Diabetologia 47(2), 2003
PMID: 14666367
Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.
Dor Y, Brown J, Martinez OI, Melton DA., Nature 429(6987), 2004
PMID: 15129273
The source(s) for new pancreatic beta cells in adult life.
Bock T., Bioessays 26(11), 2004
PMID: 15499581
Evidence that somatomedin is synthesized by multiple tissues in the fetus.
D'Ercole AJ, Applewhite GT, Underwood LE., Dev. Biol. 75(2), 1980
PMID: 7372001
Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum.
Moses AC, Nissley SP, Short PA, Rechler MM, White RM, Knight AB, Higa OZ., Proc. Natl. Acad. Sci. U.S.A. 77(6), 1980
PMID: 6932040
Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.
Bonner-Weir S, Trent DF, Weir GC., J. Clin. Invest. 71(6), 1983
PMID: 6134752
Developmental regulation of insulin-like growth factor II mRNA in different rat tissues.
Brown AL, Graham DE, Nissley SP, Hill DJ, Strain AJ, Rechler MM., J. Biol. Chem. 261(28), 1986
PMID: 3759952
A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.
DeChiara TM, Efstratiadis A, Robertson EJ., Nature 345(6270), 1990
PMID: 2330056
Parental imprinting of the mouse insulin-like growth factor II gene.
DeChiara TM, Robertson EJ, Efstratiadis A., Cell 64(4), 1991
PMID: 1997210
A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.
Christofori G, Naik P, Hanahan D., Nature 369(6479), 1994
PMID: 7910953
Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis.
Christofori G, Naik P, Hanahan D., Nat. Genet. 10(2), 1995
PMID: 7663515
Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor.
Petrik J, Arany E, McDonald TJ, Hill DJ., Endocrinology 139(6), 1998
PMID: 9607811
Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.
Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR., Cell 96(3), 1999
PMID: 10025399
Regulation of pancreatic beta-cell mass.
Bouwens L, Rooman I., Physiol. Rev. 85(4), 2005
PMID: 16183912
Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk.
Kaneda A, Feinberg AP., Cancer Res. 65(24), 2005
PMID: 16357124
Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas.
Hao E, Tyrberg B, Itkin-Ansari P, Lakey JR, Geron I, Monosov EZ, Barcova M, Mercola M, Levine F., Nat. Med. 12(3), 2006
PMID: 16491084
Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus.
De Leon DD, Crutchlow MF, Ham JY, Stoffers DA., Int. J. Biochem. Cell Biol. 38(5-6), 2005
PMID: 16202636
Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer.
Cui H., Dis. Markers 23(1-2), 2007
PMID: 17325430
Defective IGF2 and IGF1R protein production in embryonic pancreas precedes beta cell mass anomaly in the Goto-Kakizaki rat model of type 2 diabetes.
Calderari S, Gangnerau MN, Thibault M, Meile MJ, Kassis N, Alvarez C, Portha B, Serradas P., Diabetologia 50(7), 2007
PMID: 17476475
Facultative endocrine progenitor cells in the adult pancreas.
Dor Y, Melton DA., Cell 132(2), 2008
PMID: 18243094
Regulated beta-cell regeneration in the adult mouse pancreas.
Cano DA, Rulifson IC, Heiser PW, Swigart LB, Pelengaris S, German M, Evan GI, Bluestone JA, Hebrok M., Diabetes 57(4), 2007
PMID: 18083786
PANIC-ATTAC: a mouse model for inducible and reversible beta-cell ablation.
Wang ZV, Mu J, Schraw TD, Gautron L, Elmquist JK, Zhang BB, Brownlee M, Scherer PE., Diabetes 57(8), 2008
PMID: 18469203
Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss.
Thorel F, Nepote V, Avril I, Kohno K, Desgraz R, Chera S, Herrera PL., Nature 464(7292), 2010
PMID: 20364121
Integrating semantic annotation and information visualization for the analysis of multichannel fluorescence micrographs from pancreatic tissue.
Herold J, Zhou L, Abouna S, Pelengaris S, Epstein D, Khan M, Nattkemper TW., Comput Med Imaging Graph 34(6), 2009
PMID: 19969439
Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats.
Li WC, Rukstalis JM, Nishimura W, Tchipashvili V, Habener JF, Sharma A, Bonner-Weir S., J. Cell. Sci. 123(Pt 16), 2010
PMID: 20663919
Glucose and aging control the quiescence period that follows pancreatic beta cell replication.
Salpeter SJ, Klein AM, Huangfu D, Grimsby J, Dor Y., Development 137(19), 2010
PMID: 20823063
Non-β-cell progenitors of β-cells in pregnant mice.
Abouna S, Old RW, Pelengaris S, Epstein D, Ifandi V, Sweeney I, Khan M., Organogenesis 6(2), 2010
PMID: 20885859
c-Myc directly induces both impaired insulin secretion and loss of β-cell mass, independently of hyperglycemia in vivo.
Cheung L, Zervou S, Mattsson G, Abouna S, Zhou L, Ifandi V, Pelengaris S, Khan M., Islets 2(1), 2010
PMID: 21099292
Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells.
Xuan S, Szabolcs M, Cinti F, Perincheri S, Accili D, Efstratiadis A., J. Biol. Chem. 285(52), 2010
PMID: 20947509
β-cell regeneration: the pancreatic intrinsic faculty.
Desgraz R, Bonal C, Herrera PL., Trends Endocrinol. Metab. 22(1), 2010
PMID: 21067943
Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.
Xu G, Stoffers DA, Habener JF, Bonner-Weir S., Diabetes 48(12), 1999
PMID: 10580413
Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets.
Hill DJ, Strutt B, Arany E, Zaina S, Coukell S, Graham CF., Endocrinology 141(3), 2000
PMID: 10698192
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L; LEAD-6 Study Group, Ahmed A, Alvarsson M, Anderson C, Aoki A, Aranko S, Bailey B, Barbonta D, Baur C, Bednarczyk-Kaluzny M, Blevins T, Blonde L, Bode B, Bressler P, Brusco O, Buse JB, Byrd L, Byrne M, Caldarella F, Cheatham W, Christ E, Christiansen JS, Comas LM, Cooper J, Corder C, Corser B, Courreges JP, Creteanu G, Cuddihy R, Derezinski T, Downey H, Duckor S, Eidenmuller M, Elliott S, Farrell J, Fusco F, Gaczarek-Belczyk E, Gallwitz B, Garber A, Gerber P, Gibney J, Glodowska K, Gollapudi G, Gouet D, Greco S, Grill V, Gudnason S, Guerci B, Gumprecht J, Henriksen JE, Hermansen K, Hippler S, Hoekstra J, Hoffman B, Hollander P, Jaeckel E, Jain R, Janez A, Kaiser M, Kaladas J, Kapoor A, Kayne D, Keller U, Kempe HP, Klein E, Klonoff D, Koehler L, Korytkowski M, Laine DH, Le Devehat C, Lervang HH, Levinson L, Lewin A, Lilavivat U, Lipetz R, Lubin B, Luedemann J, Madsbad S, Makela J, Marck C, Matejek N, Menendez E, Montanya E, Milenkovic T, Mira R, Moberg E, Musat D, Nolan J, Ollins R, Ortiz-Carrasquillo R, Osei K, Peterson G, Philippe J, Pietri A, Piletic M, Polaszewska-Muszynska M, Pollock J, Prager R, Radparvar A, Ratcliff L, Reed J, Reeves M, Rock K, Rosenstock J, Sall K, Schabowski J, Schernthaner G, Schmidt WE, Schwartz S, Segiet T, Serfer G, Sieradzki J, Smith D, Softeland E, Solano FV, Stasinska T, Staut M, Stearns P, Stoll M, Strand J, Tamayo R, Toplak H, Townsend R, Vaag A, Vance C, Wascher T, Weinstein R, Weiss D, Wendisch U, Wenzl-Bauer V, Whittier F, Wizemann E, Yeoman G, Yki-Jarvinen H., Lancet 374(9683), 2009
PMID: 19515413
Regulation of beta-cell mass by hormones and growth factors.
Nielsen JH, Galsgaard ED, Moldrup A, Friedrichsen BN, Billestrup N, Hansen JA, Lee YC, Carlsson C., Diabetes 50 Suppl 1(), 2001
PMID: 11272193
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 22970135
PubMed | Europe PMC

Suchen in

Google Scholar